Telix Pharmaceuticals Limited

📍 North Melbourne, Australia👥 665 employees💰 Last funded May 2026
Pharmaceutical Manufacturing🌐 telixpharma.com
Website LinkedIn
Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic (theranostic) radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Telix Pharmaceuticals Limited?
Telix Pharmaceuticals Limited has 1 investors on record on gritt.io.
When did Telix Pharmaceuticals Limited last raise funding?
The most recent investment in Telix Pharmaceuticals Limited recorded on gritt.io was in May 2026.
What industry is Telix Pharmaceuticals Limited in?
Telix Pharmaceuticals Limited operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Telix Pharmaceuticals Limited based?
Telix Pharmaceuticals Limited is headquartered in North Melbourne, Australia.